Liposomal delivery systems for anti-cancer analogues of vitamin e

Journal of Controlled Release

Volumn 207, Issue , 2015, Pages 59-69

  Koudelka, Stepan ^a,b   Turanek Knotigova, Pavlina ^a   Masek, Josef ^a   Prochazka, Lubomir ^a   Lukac, Robert ^a   Miller, Andrew D ^c   Neuzil, Jiri ^d,e   Turanek, Jaroslav ^a  

^a VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GRIFFITH UNIVERSITY   (Australia)

^e INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

Author keywords

Alpha tocopheryl succinate; Analogues of vitamin E; Anti cancer drugs; Apoptosis; Drug delivery systems; Drug targeting; Liposome; Nanomedicine

Indexed keywords

BIOACTIVITY; BIOCOMPATIBILITY; CELL DEATH; DRUG DELIVERY; DRUG INTERACTIONS; LIPOSOMES; MEDICAL NANOTECHNOLOGY;

ALPHA-TOCOPHERYL SUCCINATE; ANTICANCER DRUG; DRUG DELIVERY SYSTEM; DRUG-TARGETING; VITAMIN-E;

DISEASES;

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; LIPOSOME; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; LIPID;

AEROSOL; ANTINEOPLASTIC ACTIVITY; APOPTOGENIC ACTIVITY; BILAYER MEMBRANE; CANCER IMMUNOTHERAPY; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; LIPOSOMAL DELIVERY; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; MEDICINAL CHEMISTRY; NEOPLASMS; PATHOLOGY; PROCEDURES; SOLUBILITY;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; LIPOSOMES; NEOPLASMS; SOLUBILITY; VITAMIN E;

EID: 84927154729     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.04.003     Document Type: Review

References (105)

1. K. Fukuzawa, K. Matsuura, A. Tokumura, A. Suzuki, and J. Terao Kinetics and dynamics of singlet oxygen scavenging by alpha-tocopherol in phospholipid model membranes Free Radic. Biol. Med. 22 1997 923 930
2. S. Urano, M. Kitahara, Y. Kato, Y. Hasegawa, and M. Matsuo Membrane stabilizing effect of vitamin E - existence of a hydrogen bond between alpha-tocopherol and phospholipids in bilayer liposomes J. Nutr. Sci. Vitaminol. 36 1990 513 519
3. Z. Djuric, L.K. Heilbrun, S. Lababidi, C.K. Everett-Bauer, and M.W. Fariss Growth inhibition of MCF-7 and MCF-1OA human breast cells by alpha-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs Cancer Lett. 111 1997 133 139
4. W.P. Yu, B.G. Sanders, and K. Kline RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest Nutr. Cancer 27 1997 92 101
5. W.P. Yu, M. Simmons-Menchaca, A. Gapor, B.G. Sanders, and K. Kline Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols Nutr. Cancer 33 1999 26 32
6. M.W. Fariss, M.B. Fortuna, C.K. Everett, J.D. Smith, D.F. Trent, and Z. Djuric The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia-cells result from the action of the intact compounds Cancer Res. 54 1994 3346 3351
7. J. Neuzil, T. Weber, N. Gellert, and C. Weber Selective cancer cell killing by alpha-tocopheryl succinate Br. J. Cancer 84 2001 87 89
8. J. Neuzil, M. Tomasetti, A.S. Mellick, R. Alleva, B.A. Salvatore, M. Birringer, and M.W. Fariss Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects Curr. Cancer Drug Targets 4 2004 355 372
9. T. Weber, M. Lu, L. Andera, H. Lahm, N. Gellert, M.W. Fariss, V. Korinek, W. Sattler, D.S. Ucker, A. Terman, A. Schroder, W. Erl, U.T. Brunk, R.J. Coffey, C. Weber, and J. Neuzil Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo Clin. Cancer Res. 8 2002 863 869
10. K.T. Barnett, F.D. Fokum, and M.P. Malafa Vitamin E succinate inhibits colon cancer liver metastases J. Surg. Res. 106 2002 292 298
11. A. Hrzenjak, H. Reicher, A. Wintersperger, B. Steinecker-Frohnwieser, P. Sedlmayr, H. Schmidt, T. Nakamura, E. Malle, and W. Sattler Inhibition of lung carcinoma cell growth by high density lipoprotein-associated alpha-tocopheryl-succinate Cell. Mol. Life Sci. 61 2004 1520 1531
12. M.P. Malafa, F.D. Fokum, A. Mowlavi, M. Abusief, and M. King Vitamin E inhibits melanoma growth in mice Surgery 131 2002 85 91
13. M.P. Malafa, F.D. Fokum, J. Andoh, L.T. Neitzel, S. Bandyopadhyay, R. Zhan, M. Iiizumi, E. Furuta, E. Horvath, and K. Watabe Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis Int. J. Cancer 118 2006 2441 2447
14. L.V. Ramanathapuram, T. Hahn, S.M. Dial, and E.T. Akporiaye Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination Nutr. Cancer 53 2005 177 193
15. M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P.K. Witting, A. Procopio, and J. Neuzil Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop J. Biol. Chem. 280 2005 25369 25376
16. E. Swettenham, P.K. Witting, B.A. Salvatore, and J. Neuzil Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system J. Neurochem. 94 2005 1448 1456
17. N. Duhem, F. Danhier, and V. Preat Vitamin E/based nanomedicines for anti-cancer drug delivery J. Control. Release 182 2014 33 34
18. J. Neuzil, K. Kagedal, L. Andera, C. Weber, and U.T. Brunk Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity Apoptosis 7 2002 179 187
19. H.J. Kayden, and M.G. Traber Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans J. Lipid Res. 34 1993 343 358
20. J. Neuzil, and H. Massa Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion Biochem. Biophys. Res. Commun. 327 2005 1024 1027
21. P.J. Pussinen, H. Lindner, O. Glatter, H. Reicher, G.M. Kostner, A. Wintersperger, E. Malle, and W. Sattler Lipoprotein-associated alpha-tocopheryl succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells Biochim. Biophys. Acta 1485 2000 129 144
22. J. Neuzil, T. Weber, A. Schroder, M. Lu, G. Ostermann, N. Gellert, G.C. Mayne, B. Olejnicka, A. Negre-Salvayre, M. Sticha, R.J. Coffey, and C. Weber Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements FASEB J. 15 2001 403 415
23. S. Yamamoto, H. Tamai, R. Ishisaka, T. Kanno, K. Arita, H. Kobuchi, and K. Utsumi Mechanism of alpha-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells Free Radic. Res. 33 2000 407 418
24. M.A. Tirmenstein, X.K. Ge, C.R. Elkins, and M.W. Fariss Administration of the tris salt of alpha-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal alpha-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity Free Radic. Biol. Med. 26 1999 825 835
25. J. Neuzil, M. Tomasetti, Y. Zhao, L.F. Dong, M. Birringer, X.F. Wang, P. Low, K. Wu, B.A. Salvatore, and S.J. Ralph Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent Mol. Pharmacol. 71 2007 1185 1199
26. K. Kogure, S. Manabe, I. Suzuki, A. Tokumura, and K. Fukuzawa Cytotoxicity of alpha-tocopheryl succinate, malonate and oxalate in normal and cancer cells in vitro and their anti-cancer effects on mouse melanoma in vivo J. Nutr. Sci. Vitaminol. 51 2005 392 397
27. J. Turanek, X.F. Wang, P. Knotigova, S. Koudelka, L.F. Dong, E. Vrublova, E. Mahdavian, L. Prochazka, S. Sangsura, A. Vacek, B.A. Salvatore, and J. Neuzil Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice Toxicol. Appl. Pharmacol. 237 2009 249 257
28. K.N. Prasad, and J. Edwards-Prasad Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth-inhibition in melanoma cells in culture Cancer Res. 42 1982 550 555
29. M. Birringer, J.H. Eytina, B.A. Salvatore, and J. Neuzil Vitamin E analogues as inducers of apoptosis: structure-function relation Br. J. Cancer 88 2003 1948 1955
30. E. Mahdavian, S. Sangsura, G. Landry, J. Eytina, and B.A. Salvatore A novel synthesis of tocopheryl amines and amides Tetrahedron Lett. 50 2009 19 21
31. A. Tomic-Vatic, J. Eytina, J. Chapman, E. Mahdavian, J. Neuzil, and B.A. Salvatore Vitamin E amides, a new class of vitamin E analogues with enhanced proapoptotic activity Int. J. Cancer 117 2005 188 193
32. K. Anderson, M. Simmons-Menchaca, K.A. Lawson, J. Atkinson, B.G. Sanders, and K. Kline Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, alpha-TEA Cancer Res. 64 2004 4263 4269
33. M.P. Murphy, and R.A.J. Smith Targeting antioxidants to mitochondria by conjugation to lipophilic cations Annu. Rev. Pharmacol. Toxicol. 47 2007 629 656
34. L.F. Dong, V.J.A. Jameson, D. Tilly, J. Cerny, E. Mahdavian, A. Marin-Hernandez, L. Hernandez-Esquivel, S. Rodriguez-Enriquez, J. Stursa, P.K. Witting, B. Stantic, J. Rohlena, J. Truksa, K. Kluckova, J.C. Dyason, M. Ledvina, B.A. Salvatore, R. Moreno-Sanchez, M.J. Coster, S.J. Ralph, R.A.J. Smith, and J. Neuzil Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II J. Biol. Chem. 286 2011 3717 3728
35. L. Prochazka, S. Koudelka, L.F. Dong, J. Stursa, J. Goodwin, J. Neca, J. Slavik, M. Ciganek, J. Masek, K. Kluckova, M. Nguyen, J. Turanek, and J. Neuzil Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to alpha-tocopheryl succinate Apoptosis 18 2013 286 299
36. J. Ni, X.Q. Wen, J. Yao, H.C. Chang, Y. Yin, M. Zhang, S.Z. Xie, M. Chen, B. Simons, P. Chang, A. di Sant'Agnese, E.M. Messing, and S.Y. Yeh Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway Cancer Res. 65 2005 9807 9816
37. G. Jedlitschky, I. Leier, U. Buchholz, M. Center, and D. Keppler ATP-dependent transport of glutathione s-conjugates by the multidrug resistance-associated protein Cancer Res. 54 1994 4833 4836
38. Y.H. Kang, E.M. Lee, H.J. Youk, S.H. Kim, H.J. Lee, Y.G. Park, and S.J. Lim Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells Cancer Lett. 217 2005 181 190
39. J. Yoshida, and M. Mizuno Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma J. Neuro-Oncol. 65 2003 261 267
40. J.B. Massey Interfacial properties of phosphatidylcholine bilayers containing vitamin E derivatives Chem. Phys. Lipids 109 2001 157 174
41. A.S. Janoff, C.L. Kurtz, R.L. Jablonski, S.R. Minchey, L.T. Boni, S.M. Gruner, P.R. Cullis, L.D. Mayer, and M.J. Hope Characterization of cholesterol hemisuccinate and alpha-tocopherol hemisuccinate vesicles Biochim. Biophys. Acta 941 1988 165 175
42. M.Z. Lai, N. Duzgunes, and F.C. Szoka Effects of replacement of the hydroxyl group of cholesterol and tocopherol on the thermotropic behavior of phospholipid-membranes Biochemistry 24 1985 1646 1653
43. L.T. Boni, W.R. Perkins, S.R. Minchey, L.E. Bolcsak, S.M. Gruner, P.R. Cullis, M.J. Hope, and A.S. Janoff Polymorphic phase-behavior of alpha-tocopherol hemisuccinate Chem. Phys. Lipids 54 1990 193 203
44. K. Kogure, S. Hama, M. Kisaki, H. Takemasa, A. Tokumura, I. Suzuki, and K. Fukuzawa Structural characteristic of terminal dicarboxylic moiety required for apoptogenic activity of alpha-tocopheryl esters Biochim. Biophys. Acta 1672 2004 93 99
45. A. Basu, B. Grossie, M. Bennett, N. Mills, and V. Imrhan Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil Eur. J. Nutr. 46 2007 34 43
46. L.V. Ramanathapuram, J.J. Kobie, D. Bearss, C.M. Payne, K.T. Trevor, and E.T. Akporiaye Alpha-tocopheryl succinate sensitizes established tumors to vaccination with non-matured dendritic cells Cancer Immunol. Immunother. 53 2004 580 588
47. K. Kogure, S. Manabe, S. Hama, A. Tokumura, and K. Fukuzawa Potentiation of anti-cancer effect by intravenous administration of vesiculated alpha-tocopheryl hemisuccinate on mouse melanoma in vivo Cancer Lett. 192 2003 19 24
48. X.W. Teng, N.M. Davies, C. Fukuda, R.L. Good, and M.W. Fariss Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat Biopharm. Drug Dispos. 26 2005 195 203
49. R.B. Greenwald, Z.H. Choe, J. McGuire, and C.D. Conover Effective drug delivery by PEGylated drug conjugates Adv. Drug Deliv. Rev. 55 2003 217 250
50. H.J. Youk, E. Lee, M.K. Choi, Y.J. Lee, J.H. Chung, S.H. Kim, C.H. Lee, and S.J. Lim Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol J. Control. Release 107 2005 43 52
51. D.J. Ireland, H.T. Kissick, and M.W. Bellharz Alpha-tocopheryl succinate: toxicity and lack of anti-tumour activity in immuno-competent mice Food Chem. Toxicol. 46 2008 508 512
52. A. Sharma, and U.S. Sharma Liposomes in drug delivery: progress and lipmitations Int. J. Pharm. 154 1997 123 140
53. R.D. Hofheinz, S.U. Gnad-Vogt, U. Beyer, and A. Hochhaus Liposomal encapsulated anti-cancer drugs Anti-Cancer Drugs 16 2005 691 707
54. S. Koudelka, P. Turánek Knotigová, J. Mašek, Z. Korvasová, M. Škrabalová, J. Plocková, J. Bartheldyová, and J. Turánek Liposomes with high encapsulation capacity for paclitaxel: preparation, characterisation and in vivo anticancer effect J. Pharm. Sci. 99 2010 2309 2319
55. S. Koudelka, and J. Turanek Liposomal paclitaxel formulations J. Control. Release 163 2012 322 334
56. M. Tattersall, and S. Clarke Developments in drug delivery: implications for cancer care Curr. Opin. Oncol. 15 2003 293 299
57. S.B. Kulkarni, G.V. Betageri, and M. Singh Factors affecting microencapsulation of drugs in liposomes J. Microencapsul. 12 1995 229 246
58. T.M. Allen, and C. Hansen Pharmacokinetics of stealth versus conventional liposomes - effect of dose Biochim. Biophys. Acta 1068 1991 133 141
59. P.S. Uster, T.M. Allen, B.E. Daniel, C.J. Mendez, M.S. Newman, and G.Z. Zhu Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time FEBS Lett. 386 1996 243 246
60. M.C. Woodle, and D.D. Lasic Sterically stabilized liposomes Biochim. Biophys. Acta 1113 1992 171 199
61. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, and R.K. Jain Vascular-permeability in a human tumor xenograft - molecular-size dependence and cutoff size Cancer Res. 55 1995 3752 3756
62. P. Sapra, and T.M. Allen Ligand-targeted liposomal anticancer drugs Prog. Lipid Res. 42 2003 439 462
63. P.J. Quinn Localization of vitamin E in membranes P.J. Quinn, V.E. Kagan, Subcellular Biochemistry: Fat-Soluble Vitamins 1998 Plenum Press Inc. New York 319 343
64. P.J. Quinn Is the distribution of alpha-tocopherol in membranes consistent with its putative functions? Biochem. Mosc. 69 2004 58 66
65. J. Villalain, F.J. Aranda, and J.C. Gomez-Fernandez Calorimetric and infrared spectroscopic studies of the interaction of alpha-tocopherol and alpha-tocopheryl acetate with phospholipid-vesicles Eur. J. Biochem. 158 1986 141 147
66. G. Neunert, P. Polewski, M. Markiewicz, P. Walejko, S. Witkowski, and K. Polewski Partition of tocopheryl glucopyranoside into liposome membranes studied by fluorescence methods Biophys. Chem. 146 2010 92 97
67. S. Koudelka, J. Masek, J. Neuzil, and J. Turanek Lyophilised liposome-based formulations of alpha-tocopheryl succinate: preparation and physico-chemical characterisation J. Pharm. Sci. 99 2010 2434 2443
68. Y. Asai Structural differences in aqueous dispersions of alpha-tocopheryl acetate and phosphatidylcholine upon varying their molar fractions Pharmazie 59 2004 849 853
69. K. Kawakami, Y. Nishihara, and K. Hirano Liposome/emulsion transition induced by alpha-tocopheryl acetate Langmuir 15 1999 7454 7460
70. L.M. Crowe, J.H. Crowe, A. Rudolph, C. Womersley, and L. Appel Preservation of freeze-dried liposomes by trehalose Arch. Biochem. Biophys. 242 1985 240 247
71. J.A. Zhang, G. Anyarambhatla, L. Ma, S. Ugwu, T. Xuan, T. Sardone, and I. Ahmad Development and characterization of a novel Cremophor (R) EL free liposome-based paclitaxel (LEP-ETU) formulation Eur. J. Pharm. Biopharm. 59 2005 177 187
72. S. Hama, S. Utsumi, Y. Fukuda, K. Nakayama, Y. Okamura, H. Tsuchiya, K. Fukuzawa, H. Harashima, and K. Kogure Development of a novel drug delivery system consisting of an antitumor agent tocopheryl succinate J. Control. Release 161 2012 843 851
73. X.B. Gu, J.L. Schwartz, X.W. Pang, Y.F. Zhou, D.A. Sirois, and R. Sridhar Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture Cancer Lett. 239 2006 281 291
74. H. Harar, J. Gorin, H. Shmeeda, and A. Gabizon Characterization of a liposomal formulation of alpha-tocopherol succinate for cancer therapy Ann. Oncol. 18 2007 38
75. H. Karanth, and R.S.R. Murthy pH-sensitive liposomes - principle and application in cancer therapy J. Pharm. Pharmacol. 59 2007 469 483
76. S. Simoes, J.N. Moreira, C. Fonseca, N. Duzgunes, and M.C.P. de Lima On the formulation of pH-sensitive long circulation times Adv. Drug Deliv. Rev. 56 2004 947 965
77. H. Jizomoto, E. Kanaoka, and K. Hirano pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate Biochim. Biophys. Acta 1213 1994 343 348
78. H. Xu, Y.H. Deng, K.Q. Wang, and D.W. Chen Preparation and characterization of stable ph-sensitive vesicles composed of alpha-tocopherol hemisuccinate AAPS PharmSciTech 13 2012 1377 1385
79. V. Knight, N.V. Koshkina, J.C. Waldrep, B.C. Giovanella, and B.E. Gilbert Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice Cancer Chemother. Pharmacol. 44 1999 177 186
80. N.V. Koshkina, B.E. Gilbert, J.C. Waldrep, A. Seryshev, and V. Knight Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice Cancer Chemother. Pharmacol. 44 1999 187 192
81. K.A. Lawson, K. Anderson, M. Simmons-Menchaca, J. Atkinson, L.Z. Sun, B.G. Sanders, and K. Kline Comparison of vitamin E derivatives alpha-TEA and VES in reduction of mouse mammary tumor burden and metastasis Exp. Biol. Med. 229 2004 954 963
82. K.A. Lawson, K. Anderson, M. Menchaca, J. Atkinson, L.Z. Sun, V. Knight, B.E. Gilbert, C. Conti, B.G. Sanders, and K. Kline Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis Mol. Cancer Ther. 2 2003 437 444
83. K. Anderson, K.A. Lawson, M. Simmons-Menchaca, L.Z. Sun, B.G. Sanders, and K. Kline Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis Exp. Biol. Med. 229 2004 1169 1176
84. P. Latimer, M. Menchaca, R.M. Snyder, W.P. Yu, B.E. Gilbert, B.G. Sanders, and K. Kline Aerosol delivery of liposomal formulated paclitaxel and vitamin e analog reduces murine mammary tumor burden and metastases Exp. Biol. Med. 234 2009 1244 1252
85. K.A. Lawson, K. Anderson, R.M. Snyder, M. Simmons-Menchaca, J. Atkinson, L.Z. Sun, A. Bandyopadhyay, V. Knight, B.E. Gilbert, B.G. Sanders, and K. Kline Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis Cancer Chemother. Pharmacol. 54 2004 421 431
86. S.B. Riedel, S.M. Fischer, B.G. Sanders, and K. Kline Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice Anti-Cancer Drugs 19 2008 175 181
87. S. Zhang, K.A. Lawson, M. Simmons-Menchaca, L.Z. Sun, B.G. Sanders, and K. Kline Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice Breast Cancer Res. Treat. 87 2004 111 121
88. H.M. Mansour, Y.S. Rhee, and X.A. Wu Nanomedicine in pulmonary delivery Int. J. Nanomedicine 4 2009 299 319
89. P. Zarogoulidis, E. Chatzaki, K. Porpodis, K. Domvri, W. Hohenforst-Schmidt, E.P. Goldberg, N. Karamanos, and K. Zarogoulidis Inhaled chemotherapy in lung cancer: future concept of nanomedicine Int. J. Nanomedicine 7 2012 1551 1572
90. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 56 2003 600 612
91. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 56 2003 588 599
92. P.S. Hiremath, K.S. Soppimath, and G.V. Betageri Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine Int. J. Pharm. 380 2009 96 104
93. H. Li, J.H. Song, J.S. Park, and K. Han Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor Int. J. Pharm. 258 2003 11 19
94. V. Moutardier, F. Tosini, P. Vlieghe, L. Cara, J.R. Delpero, and T. Clerc Colloidal anticancer drugs bioavailabilities in oral administration models Int. J. Pharm. 260 2003 23 38
95. H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto, and Y. Kawashima Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs Int. J. Pharm. 303 2005 160 170
96. M.Z. Fiume Final report on the safety assessment of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, potassium ascorbyl tocopheryl phosphate, and tocophersolan Int. J. Toxicol. 21 2002 51 116
97. K. Thanki, R.P. Gangwal, A.T. Sangamwar, and S. Jain Oral delivery of anticancer drugs: challenges and opportunities J. Control. Release 170 2013 15 40
98. G.M. Maghraby, B.W. Barry, and A.C. Williams Liposomes and skin: from drug delivery to model membranes Eur. J. Pharm. Sci. 34 2008 203 222
99. A. Kato, Y. Ishibashi, and Y. Miyake Effect of egg-yolk lecithin on transdermal delivery of bunazosin hydrochloride J. Pharm. Pharmacol. 39 1987 399 400
100. M. Kirjavainen, A. Urtti, I. Jaaskelainen, T.M. Suhonen, P. Paronen, R. Valjakka-Koskela, J. Kiesvaara, and J. Monkkonen Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure Biochim. Biophys. Acta 1304 1996 179 189
101. R. Natsuki, Y. Morita, S. Osawa, and Y. Takeda Effects of liposome size on penetration of dl-tocopherol acetate into skin Biol. Pharm. Bull. 19 1996 758 761
102. R. Rajan, S. Jose, V.P. Mukund, and D.T. Vasudevan Transferosomes - a vesicular transdermal delivery system for enhanced drug permeation J. Adv. Pharm. Technol. Res. 2 2011 138 143
103. J.Y. Fang, P.F. Liu, and C.M. Huang Decreasing systemic toxicity via transdermal delivery of anticancer drugs Curr. Drug Metab. 9 2008 592 597
104. T. Fukao Dendritic-cell-based anticancer vaccination: has it matured Trends Immunol. 23 2002 231 232
105. L.V. Ramanathapuram, T. Hahn, M.W. Graner, E. Katsanis, and E.T. Akporiaye Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines Cancer Immunol. Immunother. 55 2006 166 177